- Home
- LVLU vs CODX Comparison
LVLU vs CODX Comparison
Compare LVLU & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVLU | CODX |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1M | 15.6M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LVLU | CODX |
|---|---|---|
| Price | $13.20 | $2.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $15.00 | ★ $67.50 |
| AVG Volume (30 Days) | ★ 1.2M | 143.0K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $285,413,000.00 | $507,892.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.53 | $18.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.98 | $2.36 |
| 52 Week High | $15.90 | $46.50 |
Technical Indicators
Market Signals| Indicator | LVLU | CODX |
|---|---|---|
| Relative Strength Index (RSI) | 92.52 | 48.63 |
| Support Level | $5.31 | $0.17 |
| Resistance Level | $15.90 | $6.35 |
| Average True Range (ATR) | 1.29 | 0.57 |
| MACD | 0.83 | 0.24 |
| Stochastic Oscillator | 73.94 | 35.48 |
Price Performance
Historical ComparisonAbout LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.